The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.
Price target range & 52-week position
Bear¥555.00Fair value¥3,924.98Bull¥5,087.09
FairClose
52-week traded range
52W low ¥2,495.5052W high ¥3,067.00
The 52-week range is measured from the stored price history, not estimated.
Valuation summary
Trading below the consensus fair value
MEDIPAL HOLDINGS CORPORATION closed at ¥2,886.00, 26.5% below the consensus fair value of ¥3,924.98 drawn from 9 valuation models.
Financial DNA score 51/100 — Good. P/E of 14.0x against the 20x sector multiple the P/E model uses.
Quantitative summary only — not investment advice.
All valuation models
DCF Valuation
¥3,851.34
+33.4%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=9%, r=10%, tg=3%, n=10yr
Graham Number
¥3,840.23
+33.1%
√(22.5 × EPS × BVPS)
EPS=206.67, BVPS=3171.43
P/E Fair Value
¥4,133.40
+43.2%
EPS × 20x (sector P/E)
EPS=206.67, Sector P/E=20x
Peter Lynch (PEG)
¥1,994.37
-30.9%
EPS × Growth% (PEG = 1 is fair)
EPS=206.67, g=9.7%
EV/EBITDA
¥5,087.09
+76.3%
(EBITDA × 14.8x − Net Debt) ÷ Shares
EBITDA=70.62B
Dividend Discount (DDM)
¥3,568.83
+23.7%
D1 ÷ (r − g) where D1 = D0×(1+g)
D0=66.09, r=10%, g=8%
Book Value (P/B)
¥555.00
-80.8%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=3171.43, ROE=6.7%, g=6%, r=10%
Reverse DCF
¥2,886.00
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 2.3% | Historical: 9.7%
Margin of Safety
¥2,956.24
+2.4%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=3941.66, MoS=25%
Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.
Educational data only. Not a recommendation to buy, sell or hold any security.